The Stockholm Stock Exchange fell for the second consecutive day on Wednesday following a weak finish after initial declines on Wall Street.

At the close, the OMXS30 index was down 0.64 percent at 2,794.95. Shares worth approximately SEK 18.2 billion were traded on the Stockholm Stock Exchange.

The best performing among the exchange's major industry sectors were real estate and consumer staples, each up 0.7 percent. On the other end, technology was at the bottom, down 1.5 percent.

Among the leading stocks included in the OMXS30 index, Boliden rose 2.0 percent while Tele 2 B was up 1.7 percent. The worst performer was Sandvik, down 2.5 percent, while Addtech B declined 2.4 percent.

Medical technology company Vitrolife dropped 0.7 percent after announcing a restructuring program within its Genetic Services product group and a goodwill impairment of SEK 5.4 billion linked to the acquisition of Igenomix. The measures mean that 6 percent of staff will leave and restructuring costs of SEK 55 million will be reported in the fourth quarter. The program is expected to yield annual savings of about SEK 65 million, with full effect by the end of the third quarter of 2026.

Cybersecurity company Yubico's CEO Mattias Danielsson is leaving his position. At the same time, he will assist in an orderly handover to the company's COO Jerrod Chong, who will take over as interim CEO. The share fell 5.1 percent.

Biotech company Hansa Biopharma announced that its phase 3 study with imlifidase for the treatment of anti-glomerular basement membrane disease did not meet its primary efficacy endpoint. The outcome represents a setback for the company's development program in this indication. The share plunged more than 16 percent.

Icelandic biotech company Alvotech issued guidance for next year while launching a USD 100 million bond offering. The company targets revenue of USD 650 to 700 million and adjusted EBITDA of USD 180 to 220 million, supported by higher volumes and new product launches. The share fell 4 percent.

Investment bank JP Morgan placed industrial company SKF on negative catalyst watch ahead of its fourth-quarter report on January 30. The neutral recommendation is reiterated. The target price is lowered to SEK 245 from SEK 250. The share declined 1.5 percent.

Installation company Bravida Denmark has secured a framework agreement estimated at a total value of DKK 300 million, corresponding to about SEK 438 million. At the same time, Danske Bank initiated coverage of Bravida with a buy recommendation. The share rose 0.4 percent.

Animal health company Swedencare has presented new financial targets for the next five years. The targets include achieving double-digit annual organic growth. The share increased nearly 7 percent.

Steel company SSAB saw its A share rise 0.1 percent. Two of its North American competitors, Nucor and Steel Dynamics, lowered their forecasts for the fourth quarter.

Road maintenance company Terranor was down more than 7 percent. The company's major German shareholder, Mutares Holding-39, has sold 2.5 million shares, corresponding to 12.5 percent of the capital, in the company. The sale was made to a limited number of Swedish and international institutional investors as well as other qualified investors.

On the analysis front, SEB also upgraded industrial company AQ to buy from hold. The share initially rose but closed down 0.5 percent.

DNB Carnegie, SEB, and SB1 Markets initiated coverage of game developer Coffee Stain with a buy recommendation, while Nordea started with a hold. The share increased 1.4 percent.

Nordea resumed coverage of gaming company Embracer with a buy recommendation. The share rose 3.4 percent.

Handelsbanken downgraded technology consultancy Rejlers to hold from buy. The share fell 6.8 percent.

New Street upgraded telecom operator Tele2 to buy from neutral.

Pareto resumed coverage with a buy recommendation on hygiene and health company Essity. The B share increased 0.8 percent.